Iron chelation therapy with deferiprone improves oxidative status and red blood cell quality and reduces redox-active iron in β-thalassemia/hemoglobin E patients

by Noppawan Phumala Morales, Supot Rodrat, Pannaree Piromkraipak, Paveena Yamanont, Kittiphong Paiboonsukwong, Suthat Fucharoen
Published 2022

Comparison of pharmacokinetics and urinary iron excretion of two single doses of deferiprone in β-Thalassemia/hemoglobin e patients

by Supot Rodrat, Pavena Yamanont, Jeeranut Tankanitlert, Udom Chantraraksri, Suthat Fucharoen, Noppawan Phumala Morales
Published 2018